Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
27,41 USD | +3,92% | +2,97% | -2,42% |
28/05 | Sectorupdate: Gezondheidszorgaandelen gemengd voor de beurs op dinsdag | MT |
28/05 | Agios Pharmaceuticals verkoopt 15% royaltyrechten op vorasidenib aan Royalty Pharma voor $905 miljoen | MT |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical Royalties
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 237 | 100,0 % | 2 355 | 100,0 % | +5,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01-01-96 |
Terrance Coyne
DFI | Director of Finance/CFO | 42 | 01-01-10 |
Arthur McGivern
CIO | Chief Investment Officer | - | 12-10-22 |
Marshall Urist
CTO | Chief Tech/Sci/R&D Officer | 48 | 01-01-13 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-23 |
James Reddoch
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-07-08 |
Brienne Kugler
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-14 |
Sara Klymkowsky
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-12 |
George Lloyd
CIO | Chief Investment Officer | 64 | 01-01-11 |
George Grofik
IRC | Investor Relations Contact | - | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rory Riggs
FOU | Founder | 71 | 01-01-96 |
Errol de Souza
BRD | Director/Board Member | 70 | 01-06-20 |
David Hodgson
BRD | Director/Board Member | 67 | 23-06-22 |
Ted Love
BRD | Director/Board Member | 65 | 30-07-20 |
Henry Fernandez
BRD | Director/Board Member | 65 | 30-07-20 |
Gregory Norden
BRD | Director/Board Member | 66 | 11-02-20 |
Pablo Legorreta
CEO | Chief Executive Officer | 60 | 01-01-96 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01-06-20 |
Bonnie Bassler
BRD | Director/Board Member | 61 | 16-06-20 |
57 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 50 000 | 0 | 0 | 85,52 % |
Aandeel B | 1 | 146 456 241 | 0 | 0 | |
Aandeel C | 1 | 450 981 030 | 385 668 432 ( 85,52 %) | 0 |
Bedrijfsgegevens
Royalty Pharma Plc
110 East 59th Street 33rd floor
10022, New York
+212 883 0200
http://www.royaltypharma.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Royalty Pharma Holdings Ltd.
Royalty Pharma Holdings Ltd. Financial ConglomeratesFinance Royalty Pharma Holdings Ltd. operates as an investment holding company. The company was founded on February 10, 2020 and is headquartered in Bristol, the United Kingdom. |
Financial Conglomerates
|
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,42% | 12,36 mld. | |
+40,73% | 739 mld. | |
+31,16% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+14,75% | 240 mld. | |
+9,44% | 210 mld. | |
-5,11% | 206 mld. | |
+6,17% | 164 mld. |
- Beurs
- Aandelen
- Koers RPRX
- Onderneming Royalty Pharma plc